Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1613-7671
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna ; day:27 ; month:1 ; year:2017 ; pages:1-10
Wiener klinische Wochenschrift ; (27.1.2017), 1-10
- Creator
-
Steiner, Sebastian
- Contributor
-
Bucsics, Theresa
Schwabl, Philipp
Mandorfer, Mattias
Scheiner, Bernhard
Aichelburg, Maximilian Christopher
Grabmeier-Pfistershammer, Katharina
Ferenci, Peter
Trauner, Michael
Peck-Radosavljevic, Markus
Reiberger, Thomas
SpringerLink (Online service)
- DOI
-
10.1007/s00508-016-1162-y
- URN
-
urn:nbn:de:1111-2017022210169
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Steiner, Sebastian
- Bucsics, Theresa
- Schwabl, Philipp
- Mandorfer, Mattias
- Scheiner, Bernhard
- Aichelburg, Maximilian Christopher
- Grabmeier-Pfistershammer, Katharina
- Ferenci, Peter
- Trauner, Michael
- Peck-Radosavljevic, Markus
- Reiberger, Thomas
- SpringerLink (Online service)
Other Objects (12)
Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
B-type natriuretic peptide (BNP) in HCV-positive Egyptian patients: the impact of HCV eradication on plasma BNP levels
Cross-sectional study to determine prevalence of significant liver fibrosis (F2–F4) in HIV/HCV co-infected patients: GRAFIHCO study
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Evaluation of HCV-related liver fibrosis post-successful DAA therapy
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI)
Novel biomarkers assist in detection of liver fibrosis in HCV patients
Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
B-type natriuretic peptide (BNP) in HCV-positive Egyptian patients: the impact of HCV eradication on plasma BNP levels
Cross-sectional study to determine prevalence of significant liver fibrosis (F2–F4) in HIV/HCV co-infected patients: GRAFIHCO study
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Evaluation of HCV-related liver fibrosis post-successful DAA therapy
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI)
Novel biomarkers assist in detection of liver fibrosis in HCV patients
Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
B-type natriuretic peptide (BNP) in HCV-positive Egyptian patients: the impact of HCV eradication on plasma BNP levels
Cross-sectional study to determine prevalence of significant liver fibrosis (F2–F4) in HIV/HCV co-infected patients: GRAFIHCO study
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Evaluation of HCV-related liver fibrosis post-successful DAA therapy
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI)